March 1, 2022
“…Enter billionaire Steven Cohen. The legendary stock picker, who began his investing career at Gruntal & Co. where he managed proprietary capital for 14 years, founded S.A.C Capital Advisors in 1992. In 2014, his investment operations were converted to Point72… Continue Reading…
July 9, 2021
“Aerpio Pharmaceuticals (ARPO) is a biopharmaceutical company focused on developing compounds that activate Tie2. Tie2 is considered a key regulator of vascular stability, and ARPO “believes that activation of Tie2 may have therapeutic potential” for different indications. In Q1, ARPO… Continue Reading…
March 25, 2021
“Oncolytics Biotech (ONCY)… Turning now to the rest of the Street, other analysts are on the same page. With 5 Buys and no Holds or Sells, the word on the Street is that ONCY is a Strong Buy. Given its… Continue Reading…
February 24, 2021
“Avalara, Inc. (AVLR)… Of the 11 analysts who have reviewed Avalara in recent weeks, 10 agree with Bracelin that this is a stock to buy, and this breakdown of 10 Buys to 1 Hold gives the company a Strong Buy analyst… Continue Reading…
January 13, 2021
“AcelRx Pharmaceuticals (ACRX)… Turning now to the rest of the Street, 3 Buys and no Holds or Sells have been published in the last three months. Therefore, ACRX has a Strong Buy consensus rating. Based on the $7 average price target,… Continue Reading…
December 14, 2020
“Vertex Pharmaceuticals (VRTX)… Overall, it appears that Wall Street agrees with Tenthoff. VRTX shares have a Strong Buy analyst consensus rating, based on 14 Buys and 4 Holds. The stock’s $287.50 average price target suggests it has room for 24% growth… Continue Reading…
December 2, 2020
“SOUTH SAN FRANCISCO, Calif., Nov. 30, 2020 /PRNewswire/ — Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan” or the “Company”) today announced that its Board of Directors has approved a 1-for-30 reverse stock split of the Company’s common stock, which will be effective at 5:00 p.m.… Continue Reading…
November 11, 2020
“Biotech Penny Stocks to Watch: Titan Pharmaceuticals Inc. Titan Pharmaceuticals Inc. (TTNP Stock Report) is a biotech penny stock that shot up by almost 28% by EOD on November 10th. At the beginning of the month, the company announced that… Continue Reading…
October 28, 2020
“Chromadex (CDXC)… It’s not often that the analysts all agree on a stock, so when it does happen, take note. CDXC’s Strong Buy consensus rating is based on a unanimous 3 Buys. The stock’s $7.67 average price target suggests a… Continue Reading…
October 16, 2020
“Zynerba Pharmaceuticals (ZYNE)… Turning to the rest of the Street, the bulls have it on this one. With 3 Buys and a lone Hold, the word on the Street is that ZYNE is a Strong Buy. At $13, the average… Continue Reading…
Recent Comments